Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
Tempus AI is acquiring cancer genomics partner Personalis for $1.5 billion, though the announcement triggered a decline in share prices for both companies.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Tempus AI has entered an agreement to acquire Personalis, a cancer test maker and genomics partner, in a deal valued at $1.5 billion. The acquisition aims to more tightly integrate molecular residual disease (MRD) capabilities into the AI-enabled precision oncology platform operated by Tempus.
Coverage from Reuters, Barron's, and Investor's Business Daily emphasizes the market's negative reaction, noting that shares for both companies sank following the news. Fierce Biotech and Business Wire highlight the strategic nature of the buyout regarding genomics and oncology integration.
Future developments depend on the finalization of the $1.5 billion deal and the subsequent integration of Personalis's technology into the Tempus AI platform.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 6h ago.
Quick answers
How much is Tempus AI paying for Personalis?
The deal is valued at $1.5 billion.
What is the strategic goal of the acquisition?
Tempus intends to more tightly integrate molecular residual disease (MRD) into its AI-enabled precision oncology platform.
How did the stock market respond to the news?
Shares for both Tempus AI and Personalis dived or sank following the announcement.
Coverage (5)
- Tempus buys out cancer genomics partner Personalis in $1.5 billion deal Fierce Biotech · 15h ago
- Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform Business Wire · 15h ago
- Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink Barron's · 15h ago
- Tempus to buy cancer test maker Personalis for $1.5 billion Reuters · 15h ago
- Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive Investor's Business Daily · 15h ago broke it first
People, places & organizations
Topics
Related trends
Brookfield and CPP Investments to Buy LXP Industrial for $5.2 Billion
Brookfield and CPP Investments have agreed to take LXP Industrial private in a deal valued at $5.2 billion.
Banijay and Mediawan Eye Lionsgate Studios Takeover
7 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
A $3.2 Trillion Deal-Making Frenzy Is Spurred by the A.I. Economy
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Blockbuster AI Deal Shows Why Honeywell Had to Break Up
7 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
EasyJet Agrees to Castlelake’s £5.2 Billion Takeover Offer
EasyJet has agreed in principle to a multi-billion pound takeover bid from US-based investment firm Castlelake.
ON Semiconductor strikes $7 billion deal for Synaptics in physical AI push
ON Semiconductor strikes $7 billion deal for Synaptics